Syneos: Shareholders approve $7B plan to go private

MORRISVILLE – Syneos Health, a global life science contract research organization, is moving closer to going private in a deal worth $7 billion.

Shareholders on Wednesday voted in favor of the plan, the company announced. It did not disclose the vote total.

The deal was announced in May.

“We thank our stockholders for their strong support for this transaction,” said Michelle Keefe, CEO of Syneos Health, in an announcement. “We look forward to closing the transaction, further executing on our growth priorities, and driving customer success by delivering fit-for-purpose, integrated solutions that help them bring life-saving therapies to patients.”

Shareholders will receive $43 for each share they own.

Leading the buyout are Elliott Investment Management L.P., Patient Square Capital, and Veritas Capital.

The deal is expected to close later this year.

‘Evolve the organization:’ Inside Syneos Health’s $7.1B private equity deal